Since our creation, we have been empowering agribusinesses through R&D, innovation, product diversification and positive marketing, all of which contribute to leverage their success in competitive markets. Our team of scientists, academics and community members is specialized in assisting small- and medium-size enterprises maximize investor attraction, achieve financial goals, increase productivity and cause a positive social impact.


Below, you will find a few examples of how our consulting work and our ideas have helped businesses diversify and boost their activities, using innovation in microbiology, molecular sciences, fermentation techniques, hardware and software development, and animal biomonitoring.

PROJECT 1 – Identification of therapeutic value among wildlife molecules

Wildlife is becoming increasingly popular for their ability to produce molecules with therapeutic application, specially against human chronic diseases and infections. In our laboratories, we found that microorganisms intrinsically associated with Australian wildlife play a significant role in both preventing and resolving some of these issues. Our work with the SNC Agri group led to the identification of microbes with potential to serve as novel and more powerful probiotics. Also, we are currently investigating the therapeutic potential of recombinant molecules that were designed based on wildlife genes, and which are about to be assessed as tools in the fight against human and animal diseases.

PROJECT 2 – Microbial discovery, characterization and commercial application

Biodiversity involves the co-existence of different species of animals, plants and microorganisms in a particular ecosystem, whereby each one plays a critical role in its homeostasis. It is known that the loss of one or more species can have environmental implications, and in extreme cases pose a major global threat, and of particular importance are fungi, bacteria and algae. In fact, some of these require a suitable environment with specific temperature, pH, salinity, substrates, in/organic matter, growth factors and quorum sensing molecules which allow them to survive and thrive. In addition, many microbes appear to play a role in bioremediation and production of pharmaceutical compounds. However, several species will disappear in the next few years, as they are pushed to the limit of their evolutionary plasticity while attempting to survive in a constantly changing world.

Furthermore, since cultivable microorganisms that grow under laboratory conditions represent only 1% of the known microbiota, it is plausible that many species will become extinct before they can be discovered and assessed regarding their biotechnological potential.

Baring this in mind, the Environmate group has approached us aiming to (i) identify and conserve novel microbial species, (ii) provide important insights into the discovery and development of novel therapeutics for the control of multidrug resistance, and (iii) produce microorganisms of medical and agricultural importance using fermentation.


R. Stephens
Tasmanian Honey
for Honey Connoisseurs